• Reengineering Pathology Bot by Bot

    Sep 02 | Diagnostics World | Artificial intelligence can help reengineer pathology toward the point of care and provide guidance to first-on-the-scene responders, including those in military battlefields with no internet connectivity and limited medical training. The technological possibilities are driven largely by the data foundation that AI models learn from and analyze as well as institutions finding the “Goldilocks” speed at which to move on adoption that is neither reckless nor paralyzed by fear. More

  • AI Helps Find ‘Hidden Gems’ Buried in Sleep Study Data

    Sep 01 | Diagnostics World | For decades now, doctors have been referring people suspected of having obstructive sleep apnea to a specialized medical facility for a polysomnogram (PSG). The gold-standard overnight test collects millions of data points from across the body, only a small subset of which gets prioritized for scoring the severity of the condition—notably, the apnea-hypopnea index (AHI) ranking how often their breathing slows or stops per hour of sleep. More

  • Follow the Money: Rare Kidney Disease, Limbal Stem Cell Deficiency, Biological Foundation Models

    Aug 26 | Diagnostics World | Bios Life develops a predictive platform for cancer screening and surveillance; Dash Bio advances automated bioanalysis workflows; Bridge to Life expands its organ preservation technology for transplantation; and more. More

  • Seegene’s PCR-based Test for STIs, HPV, National Health Council Launches Latest Campaign, QIAGEN Receives FDA Clearance

    Aug 25 | Diagnostics World | HanchorBio and the research team led by Professor Sung-Liang Yu of National Taiwan University enter collaboration; NORD adds three new centers to its Rare Disease Centers of Excellence Network; NeuraLight announces that its platform will be deployed as part of the Healthy Brain Ageing study; and more. More

  • Immune Biomarkers May Help Guide Psychedelic Treatments for Cancer-Related Depression

    Aug 21 | Diagnostics World | Researchers at The University of Texas MD Anderson Cancer Center are investigating whether immune-system biomarkers could help identify cancer patients most likely to benefit from rapid-acting psychedelic treatments for depression. Researchers examined whether these rapid-acting antidepressants share biological pathways that could serve as biomarkers for future treatment strategies. More

  • New Long-Read Sequencing Tool Targets Difficult-to-Detect Cancer Mutations

    Aug 20 | Diagnostics World | Analyzing genetic changes in cancer cells provides insight into how tumors develop and help with developing treatment through precision oncology. Long-read sequencing can help, but there is still a higher error rate compared to short-read sequencing. Researchers at The University of Hong Kong addressed this gap with ClairS, a tool designed to identify small cancer-related genetic mutations. More

  • Home Test for Diabetes Risk has a Leg Up on Standard Methods

    Aug 18 | Diagnostics World | The worried well the world over now have readily accessible and easy to self-administer home tests for assessing their risk for diabetes and chronic kidney disease, thanks to the computational skills of a pair of researchers at DTU Sustain, based at the Technical University of Denmark. The new online tools focus on a small number of parameters identified by artificial intelligence (AI) as being the most important among hundreds of possibilities in the long-running National Health and Nutrition Examination Survey (NHANES) in the U.S. More

  • Mapping the Brain Across Timescales May Improve Neurological Diagnostics

    Aug 13 | Diagnostics World | Researchers have uncovered evidence that the brain coordinates information across multiple timescales without requiring those processes to be synchronized moment to moment, a finding that could eventually inform new approaches to neurological and psychiatric diagnostics. More

  • Human Longevity Launches $600 Whole Genome

    Aug 11 | Diagnostics World | Human Longevity last week announced the availability of Genomics for All, a clinical-grade whole genome sequencing product priced at $599. The offering sequences all 6.4 billion base pairs of an individual's DNA and delivers AI-interpreted results through the HLI app, with no clinic visit required. More

  • New CEO for PacBio, Updated Chemistry for Vega System

    Aug 07 | Diagnostics World | PacBio made several announcements this week: Mark Van Oene is the new President and CEO for the company and new chemistry and software are available for its Vega systems. Both changes aim to position the company for wider platform adoption across labs and research areas. More
View more articles

 
DXX-Industry-spotlight

merck


Custom Diagnostic Antibody Development & Manufacturing Services

Overcome Process Challenges by outsourcing your custom antibody production to us. How partnering with an antibody production expert can improve your assay, accelerate launch, and maintain your manufacturing.

Learn more